Do Lyophilized Peptides Need to Be Shipped Cold?
A vial arriving warm is the most common cause of concern in the days after despatch, and it is usually the wrong thing to be concerned about. Lyophilization removes the reactant that drives the main degradation pathway. Once that water is gone, ordinary ambient transit is a mild environment — and the interventions intended to make it milder can introduce the one variable the drying step was there to eliminate.
The dominant degradation route for peptides in solution is hydrolysis: water attacking the peptide bond. Oxidation and microbial growth also require water, or at least benefit from it. Freeze-drying to a low residual moisture content removes the participant common to all three. What remains is a dry solid in a sealed, evacuated vial, and the chemistry that would degrade it has lost its solvent.
Published handling guidance for lyophilized peptides generally places the target below roughly 1% residual moisture, and describes properly dried material as chemically stable at ambient temperature across the transit windows couriers actually produce — commonly cited as up to about five days below 30 °C for domestic movement. Temperature still matters at the extremes; sustained exposure above roughly 40 °C is the figure usually named as the point of concern.
Where the risk actually sits
| Route | Requires | Present in a sealed dry vial |
|---|---|---|
| Hydrolysis of the peptide bond | Water | No, while the seal holds |
| Oxidation of Met, Cys, Trp | Oxygen, often moisture | Limited — vial is evacuated |
| Microbial activity | Water | No |
| Thermal stress | Sustained high temperature | Only at extremes |
| Moisture ingress | A broken seal, or condensation | The one to watch |
The last row is the interesting one, because it is the route a cold pack can open rather than close. A parcel iced at despatch, warmed through a customs hold and cooled again passes through the dew point each time it changes direction. Every crossing is an opportunity for water to condense on cold glass. Steady ambient does not do that. A package that sat at 22 °C for ten days experienced one environment; a thermally cycled package experienced several, and the transitions are the damaging part.
When cold transit is the right call
The ambient case is not universal, and stating it as though it were would be the same overreach in the opposite direction. Cold chain earns its cost where the sequence or the transit window changes the arithmetic.
- Sequences rich in oxidation-prone residues — methionine, cysteine, tryptophan.
- Sequences carrying labile bonds, such as Asp-Pro, or an N-terminal glutamine prone to cyclisation.
- Long international movements measured in weeks rather than days, particularly through warm climates.
- Material already in solution, which is a different problem entirely — the water is back, and with it the main degradation route.
- Any parcel whose seal integrity is in doubt, where the vial is no longer the controlled environment it is assumed to be.
Stored cold, shipped dry
Aurum Bio holds stock in cold storage and ships it dry. That is a deliberate distinction rather than a shortfall: cold storage addresses the long timescale, where months of accumulated thermal exposure are worth removing, and dry transit addresses the short one, where the material's own dryness is the protection and a temperature cycle is a liability.
It is also the honest description. A parcel that leaves with a gel pack and arrives four days later without a functioning one has not been cold-chain shipped; it has been shipped ambient with an expensive first afternoon. Describing the practice accurately is more useful than describing it impressively.
What arrival temperature does and does not indicate
A vial that arrives at room temperature has not, on that fact alone, been compromised. The observation carries no information about the seal, the residual moisture or the material's history before despatch. The signals that do carry information are physical and visible: an intact crimp, a stopper that has not shifted, a cake that still occupies the volume it was frozen in, and a vial that still holds reduced pressure. Those are covered in the storage and lyophilization notes elsewhere in this journal.
References
- 01Sigma-Aldrich Handling and Storage Guidelines for Peptides and Proteins. Technical document.
- 02Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS Stability of protein pharmaceuticals: an update. Pharmaceutical Research, 2010.
- 03Wang W Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics, 2000.
Every citation links out to the paper on PubMed. Identifiers are omitted deliberately rather than reproduced from memory, so where we do not hold a verified PMID or DOI the link is a PubMed search for that exact title — it resolves to the paper without anything being invented.
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. This article describes compounds and the research literature in which they appear. Nothing here is a recommendation, protocol, or statement of effect.